Asker Healthcare Group AB (OSTO:ASKER) PE Ratio: 54.81 (As of Jul. 04, 2026) — 30% Below Median


OSTO:ASKER Asker Healthcare Group AB OSTO:ASKER
13 GF Score
Price kr84.95
! 3 Warning Signs
View Full Analysis

What is Asker Healthcare Group AB PE Ratio?

Asker Healthcare Group AB OSTO:ASKER +1.13% 13 PE Ratio is 54.81 as of Jul. 04, 2026, which is 30% below its 10-year median of 78.85. GuruFocus rates OSTO:ASKER with a GF Score™ of 13/100. The stock has 3 warning signs investors should review.

The PE Ratio, or Price-to-Earnings ratio, or P/E Ratio, is a financial ratio used to compare a company's market price to its Earnings per Share (Diluted). As of today (2026-07-04), Asker Healthcare Group AB's share price is kr84.95. Asker Healthcare Group AB's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 was kr1.55. Therefore, Asker Healthcare Group AB's PE Ratio for today is 54.81.

Good Sign:

Asker Healthcare Group AB stock PE Ratio (=47.42) is close to 2-year low of 44.06.

During the past 4 years, Asker Healthcare Group AB's highest PE Ratio was 155.53. The lowest was 44.06. And the median was 78.85.

Asker Healthcare Group AB's EPS (Diluted) for the three months ended in Mar. 2026 was kr0.50. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 was kr1.55.

As of today (2026-07-04), Asker Healthcare Group AB's share price is kr84.95. Asker Healthcare Group AB's EPS without NRI for the trailing twelve months (TTM) ended in Mar. 2026 was kr1.55. Therefore, Asker Healthcare Group AB's PE Ratio without NRI ratio for today is 54.81.

During the past 4 years, Asker Healthcare Group AB's highest PE Ratio without NRI was 115.96. The lowest was 44.06. And the median was 73.24.

Asker Healthcare Group AB's EPS without NRI for the three months ended in Mar. 2026 was kr0.50. Its EPS without NRI for the trailing twelve months (TTM) ended in Mar. 2026 was kr1.55.

During the past 12 months, Asker Healthcare Group AB's average EPS without NRI Growth Rate was 62.30% per year. During the past 3 years, the average EPS without NRI Growth Rate was 0.10% per year.

During the past 4 years, Asker Healthcare Group AB's highest 3-Year average EPS without NRI Growth Rate was 0.10% per year. The lowest was 0.10% per year. And the median was 0.10% per year.

Asker Healthcare Group AB's EPS (Basic) for the three months ended in Mar. 2026 was kr0.50. Its EPS (Basic) for the trailing twelve months (TTM) ended in Mar. 2026 was kr1.55.

Back to Basics: PE Ratio


Asker Healthcare Group AB  (OSTO:ASKER) PE Ratio Explanation

The PE Ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. For example, if a company earns $2 a share per year, and the stock is traded at $30, the PE Ratio is 15. Therefore it takes 15 years for the company to earn back the $30 you paid for its stock, assuming the earnings stays constant over the next 15 years.

In real business, earnings never stay constant. If a company can grow its earnings, it takes fewer years for the company to earn back the price you pay for the stock. If a company's earnings decline it takes more years. As a shareholder, you want the company to earn back the price you pay as soon as possible. Therefore, lower P/E stocks are more attractive than higher P/E stocks so long as the PE Ratio is positive. Also for stocks with the same PE Ratio, the one with faster growth business is more attractive.

If a company loses money, the PE Ratio becomes meaningless.

To compare stocks with different growth rates, Peter Lynch invented a ratio called PEG Ratio. PEG Ratio is defined as the PE Ratio divided by the growth ratio. He thinks a company with a PE Ratio equal to its growth rate is fairly valued. Still he said he would rather buy a company growing 20% a year with a PE Ratio of 20, instead of a company growing 10% a year with a PE Ratio of 10.

Because the PE Ratio measures how long it takes to earn back the price you pay, the PE Ratio can be applied to the stocks across different industries. That is why it is the one of the most important and widely used indicators for the valuation of stocks.

Similar to the PE Ratio without NRI or PS Ratio or Price-to-Operating-Cash-Flow or Price-to-Free-Cash-Flow , the PE Ratio measures the valuation based on the earning power of the company. This is where it is different from the PB Ratio , which measures the valuation based on the company's balance sheet.


Be Aware

Investors need to be aware that the PE Ratio can be misleading a lot of times, especially when the underlying business is cyclical and unpredictable. As Peter Lynch pointed out, cyclical businesses have higher profit margins at the peaks of the business cycles. Their earnings are high and PE Ratios are artificially low. It is usually a bad idea to buy a cyclical business when the PE Ratio is low. A better ratio to identify the time to buy a cyclical businesses is the PS Ratio.

PE Ratio can also be affected by non-recurring-items such as the sale of part of businesses. This may increase for the current year or quarter dramatically. But it cannot be repeated over and over. Therefore PE Ratio without NRI is a more accurate indication of valuation than PE Ratio.


Asker Healthcare Group AB PE Ratio Related Terms


Asker Healthcare Group AB PE Ratio Historical Data

* Premium members only.

The historical data trend for Asker Healthcare Group AB's PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Asker Healthcare Group AB PE Ratio Chart

Asker Healthcare Group AB Annual Data
Trend Dec22 Dec23 Dec24 Dec25
PE Ratio
N/A N/A N/A 67.52

Asker Healthcare Group AB Quarterly Data
Dec22 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
PE Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only 113.06 129.30 77.60 67.52 44.65

OSTO:ASKER vs MCK, CAH, COR: PE Ratio Comparison

For the Medical Distribution subindustry, Asker Healthcare Group AB's PE Ratio, along with its competitors' market caps and PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Asker Healthcare Group AB PE Ratio vs Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, Asker Healthcare Group AB's PE Ratio distribution charts can be found below:

* The bar in red indicates where Asker Healthcare Group AB's PE Ratio falls into.


OSTO:ASKER
13GF Score
Asker Healthcare Group AB OSTO:ASKER
PE Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Asker Healthcare Group AB PE Ratio Calculation

The PE Ratio, or Price-to-Earnings ratio, or P/E Ratio, is a financial ratio used to compare a company's market price to its Earnings per Share (Diluted). It is the most widely used ratio in the valuation of stocks.

Asker Healthcare Group AB's PE Ratio for today is calculated as

PE Ratio=Share Price/Earnings per Share (Diluted) (TTM)
=84.95/1.550
=54.81

Asker Healthcare Group AB's Share Price of today is kr84.95.
Asker Healthcare Group AB's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was kr1.55.


* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:


There are at least three kinds of PE Ratios used by different investors. They are Trailing Twelve Month PE Ratio, Forward PE Ratio, or PE Ratio without NRI. A new PE Ratio based on inflation-adjusted normalized PE Ratio is called Shiller PE Ratio, after Yale professor Robert Shiller.

In the calculation of PE Ratio, the earnings per share used are the earnings per share over the past 12 months. For Forward PE Ratio, the earnings are the expected earnings for the next twelve months. In the case of PE Ratio without NRI, the reported earnings less the non-recurring items are used.

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. Since it looks at the average over the last 10 years, Shiller PE Ratio is also called PE10.

Frequently Asked Questions Learn more about PE Ratio →
What does a PE Ratio of 54.81 mean?
Asker Healthcare Group AB (OSTO:ASKER) has a PE Ratio of 54.81 as of Jul. 04, 2026. P/E ratio is the ratio of share price to a company's earnings per share. View historical data on Asker Healthcare Group AB and its competitors. This is 30% below median its historical median of 78.85. Over the past decade, Asker Healthcare Group AB's PE Ratio has ranged from 44.06 to 155.53.
Is Asker Healthcare Group AB's PE Ratio too high?
Asker Healthcare Group AB's current PE Ratio of 54.81 is 30% below median its 10-year median of 78.85. Over the past 10 years, this metric has ranged from a low of 44.06 to a high of 155.53. Overall, Asker Healthcare Group AB has a GF Score™ of 13/100, reflecting its overall financial health beyond just this single metric.
How does Asker Healthcare Group AB's PE Ratio compare to MCK and CAH?
Asker Healthcare Group AB's PE Ratio of 54.81 can be compared against companies in the Medical Distribution industry. Historically, Asker Healthcare Group AB's own PE Ratio has ranged from 44.06 to 155.53 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PE Ratio for a Medical Distribution company?
A good PE Ratio depends on the Medical Distribution industry context. However, PE Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PE Ratio mean?
A high PE Ratio can signal that a stock is expensive relative to its fundamentals. P/E ratio is the ratio of share price to a company's earnings per share. View historical data on Asker Healthcare Group AB and its competitors. Asker Healthcare Group AB's current PE Ratio is 54.81, which is 30% below median its own 10-year median of 78.85. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Asker Healthcare Group AB stock overvalued right now?
Asker Healthcare Group AB (OSTO:ASKER) has a current PE Ratio of 54.81. The current PE Ratio is 54.81, which is 30% below median its 10-year median of 78.85. Asker Healthcare Group AB's overall GF Score™ is 13/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PE Ratio calculated?
PE Ratio is calculated from a company's financial statements. For Asker Healthcare Group AB (OSTO:ASKER), the current PE Ratio is 54.81 as of Jul. 04, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Asker Healthcare Group AB Business Description

Other Exchanges ASKERs:UKI88:Germany
Address Svardvagen 3A, Danderyd, SWE, 182 33
Asker Healthcare Group AB is a provider of medical products and solutions that drive progress in the European healthcare sector. The company is engaged in building and acquiring companies to support the healthcare system to improve patient outcomes, reduce the total cost of care, and ensure a fair and sustainable value chain. The company also offers a range of value-added solutions to support its suppliers and customers in, for example, market access, efficiency, and sustainability. Company has adapted a twin engine growth strategy that combines organic and acquired growth. Geographically, the company evaluates the operations in three business areas: North, West and Central.
13GF Score

Get the complete analysis for OSTO:ASKER

PE Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

kr84.95
Price